Serotoninergic properties of new conformationally restricted benzamides

European Journal of Medicinal Chemistry

Volumn 31, Issue 3, 1996, Pages 231-239

  Yang, D ^a   Bremont B ^a   Shen, S ^a   Kefi, S ^a   Langlois, M ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

5 HT3 receptor antagonist; 5 HT4 receptor; Benzamide; D2 receptor; Strecker reaction

Indexed keywords

4 AMINO 5 CHLORO N (1 DIMETHYLAMINO 1 CYCLOPENTYL)METHYL 2 METHOXYBENZAMIDE; BENZAMIDE DERIVATIVE; BRL 24682; DOPAMINE 2 RECEPTOR; METOCLOPRAMIDE; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CATTLE; CONTROLLED STUDY; CORPUS STRIATUM; CRYSTAL STRUCTURE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; RAT; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 17544391197     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/0223-5234(96)89139-2     Document Type: Article

References (32)

1. Kilpatrick GJ, Bunce KT, Tyers MB (1990) Med Res Rev 10, 441-475
2. Hoyer D, Clarke DE, Fozard JR et al (1994) Pharmacol Rev 46, 157-203
3. Yakel JL, Shao XM, Jackson MB (1990) Brain Res 533, 46-52
4. Costall B, Naylor RJ, Tyers MB (1990) Pharmacol Ther 47, 181-202
5. Barnes JM, Barnes NM, Costall B et al (1990) Pharmacol Biochem Behav 37, 717-727
6. Abbott A (1990) TrendsPharm Sci 11, 49-51
7. Hesketh PJ, Gandara DR (1991) J Natl Cancer Inst 83, 613-620
8. Schmidt AW, Peroutka SJ (1989) Mol Pharmacol 36, 505-511
9. Hibert MF, Trump-Kalmeyer S, Bruinvels A, Hoflack J (1991) J Med Chem 33, 1594-1600
10. Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T (1990) J Med Chem 33, 2721-2725
11. Swain CJ, Baker R, Kneen C et al (1991) J Med Chem 34, 140-151
12. Gozlan H, Langlois M (1992) Central and Peripheral 5-HT3 Receptors (Hamon M, ed) Academic Press, London, 59-88
13. Collin S, El Tayar N, Van De Waterbeemd H et al (1989) Eur J Med Chem 24, 163-169
14. Langlois M, Yang D, Brémont B, Shen S (1995) Med Chem Lett 5, 795-798
15. Flynn DL, Zabrowski DL, Becker DP et al (1992) J Med Chem 35, 1486-1489
16. King FD, Hadley MS, Joiner KT et al (1993) J Med Chem 36, 683-689
17. Langlois M, Soulier JL, Yang D et al ( 1993) Eur J Med Chem 28, 869-880
18. Taylor EC, Macor JE (1989) J Org Chem 54, 1249-1256
19. Kalir A, Edery H, Pelah Z, Balderman D, Porath G (1969) J Med Chem 12, 473-477
20. Chauvière G, Tchoubar B, Welvart Z (1963) Bull Soc Chim France 1428-1433
21. Brown HC, Yoon NM (1966) J Am Chem Soc 88, 1464-1472
22. Salaün J (1983) J Chem Rew 83, 619-632
23. Nelson DR, Thomas DR (1989) Biochem Pharmacol 38, 1693-1695
24. Hall MD, Gozlan H, Emerit MB et al (1986) Neurochem Res 11, 891-912
25. Grossman CJ, Kilpatrick GJ, Bunce KT (1993) Br J Pharmacol 109, 618-624
26. Creese I, Hess EJ (1986) Receptor Binding in Drug Research (O'Brien RA, ed), Marcel Dekker, New York, 123-165
27. Fake CS, King FD, Sanger GJ (1987) Br J Pharmacol 91, 335P
28. Buchheit KH, Buhl T (1991) Eur J Pharmacol 205, 203-208
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) J Biol Chem 193, 265-275
30. Bradford M (1976) Anal Biochem 72, 248-254
31. Langlois M, Zhang L, Brémont B, Shen S, Manara L, Croci T (1994) BioMed Chem Lett 4, 1433-1436
32. Fadel A (1991) Tetrahedron 47, 6265-6274